Bio-Rad Laboratories, Inc. BIO.B Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s treasury stock, value?
- Bio-Rad Laboratories, Inc. (BIO.B) reported treasury stock, value of $1.01B in Q4 2025.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s treasury stock, value?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories, Inc.'s treasury stock, value has grown at a 56.5% compound annual growth rate (CAGR), from $263.59M to $1.01B.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.